-
1دورية أكاديمية
المؤلفون: Fedorenko, Olga Yu, Loonen, Anton J. M., Lang, Florian, Toshchakova, Valentina A., Boyarko, Evgenia G., Semke, Arkadiy V., Bokhan, Nikolay A., Govorin, Nikolay V., Aftanas, Lyubomir I., Ivanova, Svetlana A.
المصدر: Fedorenko , O Y , Loonen , A J M , Lang , F , Toshchakova , V A , Boyarko , E G , Semke , A V , Bokhan , N A , Govorin , N V , Aftanas , L I & Ivanova , S A 2015 , ' Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia ' , International Journal of Neuropsychopharmacology , vol. 18 , no. 6 , pp. 1-6 . https://doi.org/10.1093/ijnp/pyu098Test
مصطلحات موضوعية: gene polymorphism, medium spiny neurons, neurotoxicity, PIP5K2A, schizophrenia, tardive dyskinesia, 1 phosphatidylinositol 4 phosphate 5 kinase type IIa, phosphatidylinositol 4 phosphate kinase, unclassified drug, adult, article, disease severity, female, gene frequency, genetic variability, genotype, human, major clinical study, male, pathophysiology, prevalence, priority journal, single nucleotide polymorphism
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1093/ijnp/pyu098Test
https://hdl.handle.net/11370/8f051fb5-0a1b-4228-8f3c-3df1a7780bfdTest
https://research.rug.nl/en/publications/8f051fb5-0a1b-4228-8f3c-3df1a7780bfdTest
https://pure.rug.nl/ws/files/55679557/pyu098.pdfTest -
2
المؤلفون: Anton J. M. Loonen, Valentina A. Toshchakova, Florian Lang, Lyubomir I. Aftanas, Svetlana A. Ivanova, N. V. Govorin, Olga Yu Fedorenko, Evgenia G. Boyarko, Arkadiy V. Semke, Nikolay A. Bokhan
المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)
المصدر: International Journal of Neuropsychopharmacology
International Journal of Neuropsychopharmacology, 18(6), 1-6. Cambridge University Pressمصطلحات موضوعية: Dyskinesia, Drug-Induced, Movement disorders, PIP5K2A, genotype, medicine.medical_treatment, Pharmacology, Risk Factors, single nucleotide polymorphism, neurotoxicity, genetic variability, Pharmacology (medical), 1 phosphatidylinositol 4 phosphate 5 kinase type IIa, pathophysiology, Movement Disorders, adult, article, Middle Aged, unclassified drug, Phosphotransferases (Alcohol Group Acceptor), Psychiatry and Mental health, Phenotype, female, tardive dyskinesia, priority journal, Schizophrenia, disease severity, Abnormal Involuntary Movement Scale, medicine.symptom, Psychology, Research Article, Antipsychotic Agents, medicine.medical_specialty, Neurotoxicity Syndrome, gene polymorphism, medium spiny neurons, prevalence, gene frequency, Tardive dyskinesia, Polymorphism, Single Nucleotide, Risk Assessment, Young Adult, male, Internal medicine, otorhinolaryngologic diseases, medicine, Humans, Genetic Predisposition to Disease, human, Antipsychotic, Genetic Association Studies, Neurotoxicity, Protective Factors, medicine.disease, major clinical study, phosphatidylinositol 4 phosphate kinase, Siberia, schizophrenia, Endocrinology, Dyskinesia
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59cb5d7807f1de7b72c322fd2c7f9e22Test
https://doi.org/10.1093/ijnp/pyu098Test